Wong, Alyson W.
Lee, Tae Yoon
Johannson, Kerri A.
Assayag, Deborah
Morisset, Julie
Fell, Charlene D.
Fisher, Jolene H.
Shapera, Shane
Gershon, Andrea S.
Cox, Gerard
Halayko, Andrew J.
Hambly, Nathan
Manganas, Helene
Sadatsafavi, Mohsen
Wilcox, Pearce G.
To, Teresa
Marcoux, Veronica
Khalil, Nasreen
Kolb, Martin
Ryerson, Christopher J.
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 16 September 2020
Accepted: 19 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: Ethics approval for this project was obtained at all study centres (coordinating centre: University of British Columbia #H19-01989).
: Not applicable.
: AW reports personal fees from Boehringer-Ingelheim, outside of the submitted work. TYL, PGW, TT report no conflicts of interest. KJ reports personal fees and other from Boehringer-Ingelheim, Hoffman La Roche Ltd, Theravance, and Blade Therapeutics, grants from Chest Foundation, University of Calgary School of Medicine, Pulmonary Fibrosis Society of Calgary, UCB Biopharma SPRL, and other from Three Lakes Foundation, outside the submitted work. DA reports grants and personal fees from Boehringer-Ingelheim, and personal fees from Hoffman-La Roche Ltd. and AstraZeneca, outside the submitted work. JM reports personal fees from Boehringer-Ingelheim and Hoffman-La Roche Ltd, outside the submitted work. CDF reports grants and personal fees from the Canadian Pulmonary Fibrosis Foundation, Boehringer Ingelheim, and Roche Canada, outside of the submitted work. JHF reports grants from the Canadian Pulmonary Fibrosis Foundation, outside the submitted work. SS reports grants and personal fees from Boehringer-Ingelheim and Hoffman-La Roche Ltd. and personal fees from AstraZeneca, outside the submitted work. ASG reports no conflicts of interest. GC reports grants and personal fees from Boehringer-Ingelheim and Hoffman-La Roche Ltd, outside the submitted work. AJH reports no conflicts of interest. NH reports grants and personal fees from Actelion, Bayer, Boehringer-Ingelheim, and Hoffman-La Roche Ltd. and personal fees from Novartis, outside the submitted work. HM reports receiving grants from Prometic, outside the submitted work. MS reports honoraria from Boehringer Ingelheim, as well as research funds deposited directly to his research account at The University of British Columbia from Boehringer Ingelheim. VM reports grants from the University of Saskatchewan, the Royal University Hospital Foundation, Saskatoon, SK, and the Canadian Pulmonary Fibrosis Foundation, grants and personal fees from Boehringer-Ingelheim Canada, personal fees from Hoffman-La Roche Ltd. and AstraZeneca, outside the submitted work. NK reports grants and personal fees from Boehringer-Ingelheim, Celgene Corporation, Galapogas, outside the submitted work. MK resports grants and personal fees from Boehringer-Ingelheim and Hoffman-La Roche Ltd., GSK, Gilead and Prometic, grants from Actelion, Respivert, Alkermes and Pharmaxis, and personal fees from Genoa, Indalo and Third Pole, outside the submitted work. CJR reports grants and personal fees from Boehringer-Ingelheim and Hoffman-La Roche Ltd., outside the submitted work.